Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase 3 1

Status

Completed 6

Sponsor Class

NIH 5OTHER 1

Study Type

Interventional 6

Sponsor

Cancer Type

Plasma cell 125Lymphoid 26Gastrointestinal 26Genitourinary 21CNS 21Other hematologic neoplasm 20Sarcoma 16Thoracic 14Dermatologic 11Myeloid 7Gynecologic 6Head & Neck 4Endocrine 4Classical hematology 4Other solid neoplasm 3Breast 3Tumor-Agnostic 2NET 2Other neoplasm 1

Conditions

Carcinoma, Ovarian Epithelial 3Ovarian Neoplasms 2Endometrial Neoplasms 2Sarcoma, Endometrial Stromal 1Sarcoma 1Recurrent Uterine Corpus Sarcoma 1Fallopian Tube Neoplasms 1

Interventions

Paclitaxel 575Carboplatin 520Cisplatin 347Bevacizumab 252pembrolizumab 226Gemcitabine 157Topotecan 128liposomal doxorubicin 127Cyclophosphamide 126olaparib 120Taxes 113Radiotherapy 110Docetaxel 94Brachytherapy 89Doxorubicin 84Drug Therapy 80niraparib 75Nivolumab 71Magnetic Resonance Spectroscopy 71Specimen Handling 65fludarabine 56Biopsy 55Hyperthermic Intraperitoneal Chemotherapy 53Filgrastim 52Letrozole 50Oxaliplatin 48durvalumab 47Immunoglobulin G 47atezolizumab 46Platinum 44

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Interventional × Thalidomide × Gynecologic × Clear all
NCT00041080 2019-07-30

Tamoxifen Compared With Thalidomide in Treating Women With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

National Cancer Institute (NCI)

Phase 3 Completed
139 enrolled 10 charts
Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms

NCT00025220 2019-07-23

Thalidomide in Treating Patients With Recurrent or Persistent Cancer of the Uterus

National Cancer Institute (NCI)

Phase 2 Completed
60 enrolled
GynecologicSarcoma

Recurrent Uterine Corpus Sarcoma

NCT00004876 2013-08-26

Carboplatin With or Without Thalidomide in Treating Patients With Ovarian Epithelial Cancer

National Cancer Institute (NCI)

Phase 2 Completed
30 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

NCT00006005 2013-06-21

Thalidomide in Treating Patients With Gynecologic Sarcomas

National Cancer Institute (NCI)

Phase 2 Completed
GynecologicSarcoma

Sarcoma, Endometrial Neoplasms, Sarcoma, Endometrial Stromal

NCT00016224 2013-06-18

Thalidomide in Treating Patients With Refractory or Resistant Epithelial Ovarian Cancer

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
Gynecologic

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

NCT00025467 2013-01-24

Thalidomide in Treating Patients With Recurrent or Persistent Endometrial Cancer

National Cancer Institute (NCI)

Phase 2 Completed
60 enrolled
Gynecologic

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡